Achmea Investment Management B.V. Amgen Inc Transaction History

Achmea Investment Management B.V.

$6.06 Billion
Q3 2024

A detailed history of Achmea Investment Management B.V. transactions in Amgen Inc stock. As of the latest transaction made, Achmea Investment Management B.V. holds 18,717 shares of AMGN stock, worth $5.51 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

18,717

Previous 29,286 36.09%

Holding current value

$5.51 Million

Previous $9.15 Million 34.09%

% of portfolio

0.1%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $3.27 Million - $3.57 Million	-10,569 Reduced 36.09%	18,717 $6.03 Million
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $4.58 Million - $5.56 Million	-17,425 Reduced 37.3%	29,286 $9.15 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $7.24 Million - $8.74 Million	26,939 Added 136.25%	46,711 $13.3 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $502,961 - $567,400	1,967 Added 11.05%	19,772 $5.69 Million
Q3 2023 Nov 06, 2023	SELL	$218.65 - $271.46 $16.1 Million - $20 Million	-73,736 Reduced 80.55%	17,805 $4.79 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $187,486 - $221,698	-875 Reduced 0.95%	91,541 $20.3 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $1.72 Million - $2.1 Million	7,613 Added 8.98%	92,416 $22.3 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $5.55 Million - $7.06 Million	24,247 Added 40.04%	84,803 $20.9 Million
Q3 2022 Oct 27, 2022	SELL	$224.46 - $253.15 $77,438 - $87,336	-345 Reduced 0.57%	60,556 $13.6 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $50,525 - $56,226	-219 Reduced 0.36%	60,901 $14.8 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.3 Million - $1.44 Million	5,924 Added 10.73%	61,120 $14.8 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $11 Million - $12.6 Million	55,196 New	55,196 $12.4 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $18.3 Million - $24.2 Million	-100,316 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $1.32 Million - $1.69 Million	-6,968 Reduced 6.49%	100,316 $24.2 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $2.62 Million - $3.14 Million	-15,063 Reduced 12.31%	107,284 $20.8 Million
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $996,699 - $1.17 Million	-5,979 Reduced 4.66%	122,347 $22.5 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $362,282 - $408,371	2,003 Added 1.59%	128,326 $24.4 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $140,044 - $163,476	785 Added 0.63%	126,323 $24.6 Million
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $23.3 Million - $26.2 Million	125,538 New	125,538 $26 Million
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $14.2 Million - $15.8 Million	-84,004 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $427,927 - $488,578	2,558 Added 3.14%	84,004 $15.7 Million
Q2 2017 Aug 29, 2017	BUY	N/A	81,446	81,446 $14 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account

Achmea Investment Management B.V. Amgen Inc Transaction History